Centiva Capital’s Hims & Hers Health HIMS Stock Holding History

Centiva Capital’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,000	Closed	-$499K	–	1413
2025 Q2	$499K	Buy	+10,000	New	+$452K	0.01%	957

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Centiva Capital's HIMS Position: Q3 2025 in Review

Centiva Capital sold out of Hims & Hers Health (HIMS) in Q3 2025, closing a stake of 27,946 shares — an estimated $1.43M sold.

Centiva Capital first reported a position in HIMS in Q2 2024 and held it in 3 quarters. The position peaked at $1.51M in Q3 2024. 512 funds tracked by Wall St. Rank hold HIMS as of Q3 2025.

Centiva Capital reported no remaining Hims & Hers Health position as of Q3 2025 after selling out during the quarter.
Centiva Capital sold 27,946 Hims & Hers Health shares in Q3 2025, an estimated $1.43M.
Centiva Capital first reported a position in Hims & Hers Health in Q2 2024 and held it in 3 quarters.
Centiva Capital's Hims & Hers Health position peaked at $1.51M in Q3 2024.
512 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.